» Articles » PMID: 32283429

Prevalence of Preeclampsia and Eclampsia in Adolescent Pregnancy: A Systematic Review and Meta-analysis of 291,247 Adolescents Worldwide Since 1969

Overview
Date 2020 Apr 14
PMID 32283429
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Hypertensive disorders are among the main causes of maternal and perinatal morbidity and mortality, and the findings regarding the occurrence of preeclampsia (PE) and eclampsia (E) in adolescent pregnancy are conflicting. We performed a systematic review and meta-analysis aimed to determining the prevalence of PE and E in adolescent pregnancy considering socioeconomic and temporal characteristics.

Study Design: MEDLINE, EMBASE and SciELO databases, with no time span restrictions. Studies that reported the occurrence of PE and E in adolescent pregnancy. Study selection, data extraction and bias assessment were performed by three independent investigators. Meta-analysis techniques comprised random-effects model and double-arcsine transformation; χ and I tests were used to assess heterogeneity. Meta-regression used Hunter-Schmidt model; publication bias were assessed by funnel and Baujat plots.

Results: Seventy studies were included, ranging from 1969 to 2019 and comprising 30 countries and 291,247 adolescents. The overall prevalence rate of PE/E was 6.7 % (95 % CI = 5.8-7.6). Subgroup analysis revealed association of PE/E (P = 0.050) and E (P = 0.0113) with country income, and the highest prevalences were found in low-and medium-income country groups (11.5 %, 95 % CI=7.8-15.8 and 10.6 %, 95 % CI=6.05-16.2). Association of PE with publication year (P = 0.0022) was also found with an observable reduction in prevalence rate across the years.

Conclusions: The findings seem to confirm that socioeconomic and demographic characteristics play a role for the risk of PE/E in adolescent pregnancy. Although the occurrence of PE has declined worldwide, the problem has broader dimensions beyond health issues.

Citing Articles

Urinary miRNA Expression in Pre-Eclampsia During Early and Mid-Pregnancy.

Illarionov R, Maltseva A, Pachuliia O, Postnikova T, Vashukova E, Popova A Noncoding RNA. 2024; 10(6).

PMID: 39728606 PMC: 11677131. DOI: 10.3390/ncrna10060061.


Efficacy of vitamin D supplementation on the incidence of preeclampsia: a systematic review and meta-analysis.

Moghib K, Ghanm T, Abunamoos A, Rajabi M, Moawad S, Mohsen A BMC Pregnancy Childbirth. 2024; 24(1):852.

PMID: 39716171 PMC: 11668112. DOI: 10.1186/s12884-024-07081-y.


High sensitivity C-reactive protein in pre-eclamptic women living with HIV at a tertiary hospital in Zambia: a preliminary study.

Kabaya Z, Omar R, Kumwenda A, Muyangwa-Semenova M, Mukosha M Pan Afr Med J. 2024; 48:136.

PMID: 39554261 PMC: 11567906. DOI: 10.11604/pamj.2024.48.136.42683.


Prevalence of Preeclampsia and Eclampsia in Iran: An Updated Systematic Review and Meta-Analysis.

Abdollahpour S, Khadivzadeh T, Shafeei M, Arian M Iran J Nurs Midwifery Res. 2024; 29(5):495-502.

PMID: 39478718 PMC: 11521136. DOI: 10.4103/ijnmr.ijnmr_299_23.


Analysis of risk factors for postpartum depression after cesarean section in women with early-onset preeclampsia.

Wang R, Liang X, Su X World J Psychiatry. 2024; 14(10):1448-1457.

PMID: 39474385 PMC: 11514557. DOI: 10.5498/wjp.v14.i10.1448.